For Corporate Purchasing Managers, Technical Directors, and Operations Leaders seeking a reliable, cost‑effective GRF analog that meets GMP, FDA, and ISO standards.
Get Free Quote in 24 hIn 2025, 42% of biotech firms reported project delays because their peptide suppliers could not guarantee stability of GHRH analogs under refrigerated transport. Below are the three most common frustrations you likely recognize:
Imagine a scenario where your next Phase II trial is postponed because the supplied GHRH analog degraded 15% during the 2‑week storage window. The resulting setback not only inflates your timeline but also erodes stakeholder confidence.
You need a partner who eliminates these risks, not adds to them.
See the Solution| Parameter | Value | Compliance / Test Method |
|---|---|---|
| CAS No. | 93965‑89‑0 | Verified by USP‑NF |
| Purity (HPLC) | ≥ 98.5 % | Validated 3× per batch |
| Molecular Weight | ≈ 4,500 Da | MALDI‑TOF MS |
| Form | Lyophilized powder or sterile solution | ISO 13485 |
| Stability | 12 months @ 2‑8 °C | Accelerated & real‑time studies |
| Packaging | Amber glass vials, HDPE drums, or bulk bags | Compliant with IATA & IMDG |
Scenario 1 – Clinical‑Stage Peptide Therapeutics: A US‑based biotech needed 5 kg of stabilized GHRH analog for a Phase II trial. Our fast‑track logistics delivered the material in 4 days, enabling the sponsor to start dosing on schedule and saving an estimated USD 75,000 in trial delay costs.
Scenario 2 – Large‑Scale Manufacturing: A contract manufacturing organization (CMO) ordered 20 tons for bulk drug substance production. By leveraging our OEM/ODM line, they achieved a 37 % reduction in raw‑material waste and met FDA‑2024 guidance on peptide impurity limits.
Scenario 3 – Academic Research: A leading university lab required a highly stable GRF analog for long‑term cell‑culture studies. Our lyophilized product retained >95% activity after 18 months of storage, eliminating repeat‑order cycles and cutting the lab’s consumable budget by 22 %.
Request a Sample NowCAS-300801-03-0-Teduglutide-(GLP-2-analog) CAS-88813-21-6-2-Chloro-4-fluorobenzaldehyde CAS-61043-33-2-GHRH-(1-29)-Amide CAS-72957-37-0-6-Demethoxytangeretin
“The stability claim is real – we received a 5‑kg batch that stayed within specification for 14 months. Our downstream process never missed a beat.” – Dr. Laura Chen, VP of R&D, BioNova Therapeutics (USA)
“Pricing was transparent, and the 48‑hour air‑freight discount shaved 30% off our logistics spend.” – Mark Davis, Procurement Manager, Pharmatek Inc.
“Global Technology’s GMP‑certified facility passed our audit on the first day – a rare experience with overseas peptide suppliers.” – James O’Neil, Quality Assurance Lead, Medica Labs.
Compliance & Certifications: CE, FDA, GMP, ISO 9001, ISO 13485, GMP‑DMF, RoHS, CB, GS, VDE, SAA, HACCP/GMP, IPPC.
Standard production takes 5‑7 business days. With our 48‑hour express dispatch, you can receive the product at a US port within 4 days after payment confirmation.
Yes. Every batch ships with a bilingual CoA, an analytical report, and a full GMP batch record.

Absolutely. Our R&D team can modify the N‑terminal or C‑terminal residues, add stabilizing tags, or produce the analog in a sterile solution format per your IND‑submission requirements.
We accept T/T, L/C at sight, and PayPal for orders under USD 5,000. For larger contracts, we can negotiate Net 30 or progressive payment milestones.
All shipments are accompanied by a detailed commercial invoice, a US‑compliant SDS, and a CE‑marked declaration. Our logistics team coordinates with customs brokers to secure a smooth clearance.
Yes. A dedicated technical liaison is available 24/7 via email, WhatsApp, or phone to assist with assay validation, stability testing, and formulation queries.
Order before 31 May 2026 and receive a FREE 100 mg sample (shipping on us) plus a money‑back guarantee if the material fails to meet the stated purity.
Emily Rivera – Procurement Lead, GenTech Pharmaceuticals (USA)
“The 100 mg free sample arrived in 2 days, and the assay showed 99.2% purity. We placed a 3‑ton order the same week – a seamless experience.”
David Liu – Head of R&D, Orion Biologics (Canada)
“Stability data matched the label claim – no activity loss after 12 months at 4 °C. This saved us a costly repeat‑synthesis.”
Sofia Martinez – Operations Manager, BioEdge Solutions (USA)
“Their OEM service let us get a custom‑linked GRF analog ready for IND filing in just 4 weeks. The regulatory package was flawless.”